The trial followed patients with type 1 diabetes (T1D) for 6 months, evaluating outcomes in patients struggling to achieve glucose targets with the conventional treatment. Researchers of a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback